Portfolio: Biotechnology

Affymax, Inc.
Exited via the public markets

Alinea Pharmaceuticals, Inc.
Diabetes and related metabolic disorders

Allozyne, Inc.
Next generation protein optimization

Alnara Pharmaceuticals
Focused on developing non systemic protein therapeutics for the treatment of metabolic diseases

Arriva Pharmaceuticals, Inc.
Enzyme inhibitor replacement & therapy

ARYX Therapeutics, Inc.
Retro-metabolic drug design

Pages  1 2 3 >  Last »

Contact Us

Boston Office
The John Hancock Tower
200 Clarendon Street
54th Floor
Boston, MA 02116
Phone:  617-425-9200
Fax:  617-425-9201

San Francisco Office
601 Gateway Boulevard
Suite 350
San Francisco, CA 94080
Phone:  650-553-3300
Fax: 650-553-3301